Testing Whether Brief Use of a Virtual Reality Device Improves Gait

Weill Cornell Medicine (WCM)

Status and phase: Completed; Phase 1

Conditions: Falls, Accidental

Treatments: Device: GaitAid®

Study type: Interventional

Funder types: Other

Identifiers

NCT01936922

1303013747

Details and patient eligibility

About

A virtual reality device has already been successfully used for improving gait in adults who have neurological conditions. We will evaluate if it is feasible to study the brief use of this device in older adults who have had falls.

Full description

Older adults are at risk for recurrent falls.

This study will involve a single study session (lasting two hours) in the controlled setting of a research laboratory. This study will evaluate whether older adults who have had unintentional falls are willing to enroll in this kind of study, use the device briefly, and undergo research assessments. The study will also test whether using the virtual reality device leads to detectable changes in gait, balance, and mobility confidence. This study will lay the groundwork for more comprehensive studies in the future that will assess the clinical impact of using the device.

Twenty-four subjects will be recruited. They will include equal numbers of older adults who: (1) have fallen without a significant injury (e.g. only minor contusion, lacerations) or (2) have fallen with a significant injury (e.g. dislocation, strain/sprain, or fracture) which has healed prior to enrollment.

Each subject will complete baseline measures of gait, balance, and confidence. Then she or he will be introduced to the virtual reality device and will use it for a brief period. Gait and balance will be tested again, first with the virtual reality device and then, finally, without the virtual reality device.

The device (GaitAid®), developed by co-investigator Yoram Baram, Ph.D., has already been used for the rehabilitation of neurological patients (e.g. Parkinson's Disease). The device is a training tool and NOT a continuous walking aid.

Enrollment: 24 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

1. Age 60+.

2. English-speaking.

3. One or more unintentional falls in past year.

4. Able to ambulate for at least 10 minutes without continuous assistance, i.e., without human physical assistance and without an assistive device such as a walker, or a cane.

5. A moderate or high level of concern about falling (determined by phone screening by PI).

6. Community dwelling.

   Exclusion Criteria:

7. Diagnosed with any neurological disease, i.e., sensory ataxia, cerebellar ataxia, or spasticity of the lower limbs.

8. Diagnosed with Parkinson's Disease.

9. Diagnosed with Multiple Sclerosis.

10. Diagnosed with Cerebral Palsy.

11. Marked cognitive impairment.

12. Uses large eyeglasses to walk.

13. Vision conditions that reduce ability to use the device.

14. Severe hearing loss.

15. Unstable medical condition or terminal illness.

16. Inability to otherwise comply with the study procedures (determined by PI/study clinician).

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

24 participants in 1 patient group

Virtual reality device (GaitAid®)

Experimental group

Description:

This will be a within-subjects design. Each subject will first walk in a controlled laboratory setting as she or he would in daily life. After this, each participant will walk while using the virtual reality device (GaitAid®) for a brief period of time. The session will end with walking as usual.

Treatment:

Device: GaitAid®